graph icon

LSE:BTG PLC

15 MIN DELAY

Latest Share Price

About our products

Interventional Medicine

No company endeavours to do more to help interventional specialists in their quest to see more, reach further and treat smarter.

Learn more about Interventional Medicine

Pharmaceuticals

Our pharmaceuticals portfolio offers antidotes that alleviate acute toxicities.

Learn more about Pharmaceuticals

Named Patient Supplies

Under strict regulations, we are permitted to allow healthcare professionals access to certain products still in the pre-approval phase.

Learn more about Named Patient Supplies


  • 15 May 2018

    Financial Results Center 2018

    Results statement, webcast details, and presentation for the year ending 31 March 2018

    Find out more
  • TwoColModules (10).png

    Interventional Oncology meets Immuno-Oncology

    We're exploring how our locoregional therapies might work alongside immunotherapeutics to help drive patients’ own immune system to fight cancer.

    Learn more
  • 10 Apr 2018

    If immuno-oncology is going to be a silver bullet, we may need help with the aim.

    BTG is partnering with the Society of Interventional Oncology to support a multidisciplinary approach to turn the body’s immune system into a cancer-fighting weapon.

    Read more
  • Careers Module_TwoColModules.png

    Careers

    BTG’s success stems from the hard work and contributions of our people. As we grow, we need people who share our values and exhibit the behaviors that make working here different.

    Careers
  • Healthcare Professionals

    We are committed to ensuring that we provide full, accurate, balanced and timely information to the medical professionals who prescribe our products.

    Healthcare Professionals
  • InnovationDeve_TwoColModules.png

    Innovation

    Innovation is a continuous process at BTG that starts with the needs of patients and an in-depth knowledge of our customers.

    Innovation